Zheng Xing Xing Ye Ri Bao·2025-10-22 08:19Core Insights - The traditional Chinese medicine sector experienced a slight increase of 0.16% on October 22, with Te Yi Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Stock Performance - Te Yi Pharmaceutical (002728) closed at 11.09, up 10.02% with a trading volume of 1.1334 million shares and a transaction value of 1.201 billion [1] - Other notable gainers included Zhongsheng Pharmaceutical (002317) with a 5.22% increase, closing at 19.35, and Xinbang Pharmaceutical (002390) with a 3.89% increase, closing at 4.01 [1] - Conversely, stocks like Fangsheng Pharmaceutical (603998) and ST Xiangxue (300147) saw declines of 3.06% and 2.86%, respectively [2] Capital Flow - The traditional Chinese medicine sector saw a net outflow of 237 million in institutional funds, while retail investors contributed a net inflow of 235 million [2] - The table of capital flow indicates that Te Yi Pharmaceutical had a significant net inflow of 196 million from institutional investors, despite a net outflow from retail investors [3] - Other companies like Xinbang Pharmaceutical and Zhongsheng Pharmaceutical also experienced mixed capital flows, with varying degrees of institutional and retail investor activity [3]